EUVIMEDAtrasti EUVIMED
Randomisierte kontrollierte StudieStudienprotokollOpen access · CC BY 4.0

Targeted Cerebral Oxygenation Using Dedicated Treatment Versus Usual Care in Extremely Preterm Infants: Protocol for a Multicentre International Phase II Randomised Controlled Trial

Pranav R Jani iD, Traci-Anne Goyen iD, Kiran Kumar Balegar Virupakshappa, Rajesh Maheshwari, Dharmesh Shah, Maria Saito-Benz, Tim Schindler, James Moore, James Elhindi iD, Himanshu Popat, NIRTURE Trial Group

Journal of Paediatrics and Child Health · 2025

DOI: 10.1111/jpc.70066 ↗

At a glance

Randomisierte kontrollierte Studie in Journal of Paediatrics and Child Health, 2025. Written by Pranav R Jani and 10 co-authors. Institution: Department of Neonatology, Westmead Hospital, Westmead, Australia. Major MEDLINE topics: Brain, Hypoxia, Brain, Infant, Extremely Premature, Oxygen. Cited 1 times so far (Crossref); 55 references. The full text is freely available (open access, CC BY 4.0). Funded by: Cerebral Palsy Alliance Research Foundation.

SantraukaSubjectsBibliografiniai duomenysCiteRelated studies

Abstract (original language)

Background

Near infrared spectroscopy (NIRS) allows continuous monitoring of cerebral oxygenation and therefore has the potential to be neuroprotective. Recurrent episodes of cerebral hypo‐and/or hyperoxia may result in brain injury. The Safe‐BoosC‐II study reported stable cerebral oxygenation in extremely preterm infants by combining a dedicated treatment guideline with NIRS monitoring using several devices and adult sensors. The ability to maintain stable cerebral oxygenation with a dedicated treatment algorithm using one type of NIRS device with neonatal sensors has not been previously investigated.

Methods

In this multicentre, 2‐arm, parallel, single‐blinded, phase II RCT, stratified by gestation and hospital site, 100 participants born < 29 weeks' gestation (inborn and outborns, singleton and twins) will be randomised to targeted cerebral oxygenation using dedicated treatment or usual care with blinded cerebral NIRS monitoring for the first 5 days of life. We will exclude infants > 6 h of age, those with congenital anomaly requiring major surgery or a genetic disorder, and triples or higher multiple births. The primary outcome is the burden of cerebral hypoxia and hyperoxia for the first 5 days after birth expressed as percent hours.

Discussion

The findings of this trial will provide essential information on (i) validating results from the Safe‐BoosC‐II study, considering the differences in the study methodology between the two trials (ii) strengthening support for routine use of cerebral NIRS monitoring in this population and (iii) informing the design of future RCTs on the effects of targeted cerebral oxygenation on neurodevelopment in early childhood as the primary outcome. Trial Registration Australian New Zealand Clinical Trials Registry registration number ACTRN12621000778886

Subjects

MeSH terms (MEDLINE)

BrainHypoxia, BrainInfant, Extremely PrematureOxygenFemaleHumansInfant, NewbornMaleClinical Trials, Phase II as TopicHyperoxiaMonitoring, PhysiologicMulticenter Studies as TopicRandomized Controlled Trials as TopicSingle-Blind MethodSpectroscopy, Near-Infrared

Author keywords

cerebral oxygenationextremely preterm infantsnear infra‐red spectroscopyrandomised controlled trial

Substances

Oxygen

Authors and institutions

  • Department of Neonatology, Westmead Hospital, Westmead, Australia.
  • Faculty of Medicine and Health, The University of Sydney, Sydney, Australia.
  • Department of Neonatology, Nepean Hospital, Nepean Blue Mountains Local Health District, Kingswood, Australia.
  • Sydney Medical School Nepean, The University of Sydney, Sydney, New South Wales, Australia.
  • Neonatal Intensive Care Unit, Wellington Regional Hospital, Wellington, New Zealand.
  • Department of Paediatrics and Child Health, University of Otago, Wellington, New Zealand.

ORCID profiles: Pranav R Jani, Traci-Anne Goyen, James Elhindi

Funding

  • Cerebral Palsy Alliance Research Foundation

Cite

APA

Jani, P. R., Goyen, T. A., Virupakshappa, K. K. B., Maheshwari, R., Shah, D., Saito-Benz, M., Schindler, T., Moore, J., Elhindi, J., Popat, H., & NIRTURE Trial Group (2025). Targeted Cerebral Oxygenation Using Dedicated Treatment Versus Usual Care in Extremely Preterm Infants: Protocol for a Multicentre International Phase II Randomised Controlled Trial. Journal of Paediatrics and Child Health. https://doi.org/10.1111/jpc.70066

Vancouver

Jani PR, Goyen TA, Virupakshappa KKB, Maheshwari R, Shah D, Saito-Benz M, et al. Targeted Cerebral Oxygenation Using Dedicated Treatment Versus Usual Care in Extremely Preterm Infants: Protocol for a Multicentre International Phase II Randomised Controlled Trial. Journal of Paediatrics and Child Health. 2025. doi:10.1111/jpc.70066

BibTeX
@article{Jani2025,
  author = {Jani, Pranav R and Goyen, Traci-Anne and Virupakshappa, Kiran Kumar Balegar and Maheshwari, Rajesh and Shah, Dharmesh and Saito-Benz, Maria and Schindler, Tim and Moore, James and Elhindi, James and Popat, Himanshu and NIRTURE Trial Group, NIRTURE Trial Group},
  title = {Targeted Cerebral Oxygenation Using Dedicated Treatment Versus Usual Care in Extremely Preterm Infants: Protocol for a Multicentre International Phase II Randomised Controlled Trial},
  journal = {Journal of Paediatrics and Child Health},
  year = {2025},
  doi = {10.1111/jpc.70066}
}
Start for free →